Becton Dickinson and Co day trading at USD 265.08 per share, then rallying to 265.44 and closing at USD 263.2 per share. A net loss of -0.71% for the day. Long term pricing analysis shows the stock trading at 7.42% lower than it’s 52week high and -32.66% higher than the 52week low. The share volume traded for the day was 810K which was 0 times the 50 Day Average Volume.
Becton Dickinson and Co had a market cap of 74,452,946K as of 19th May 2020. The Earnings Per Share (EPS) for Q4 2019 is $ 3.32.
Becton Dickinson and Co are commonly known as BD is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Becton Dickinson and Co First Quarter Of Fiscal 2020.
- As reported, revenues of $4.225 billion increased by 1.6 percent.
- On a currency-neutral basis, revenues increased by 2.5 percent.
- As reported, diluted earnings per share of $0.87 decreased 57.6 percent.
- As adjusted, diluted earnings per share of $2.65 decreased 1.9 percent, or 0.4 percent on a currency-neutral basis.
- The company is lowering its full fiscal year 2020 revenue and adjusted diluted earnings per share guidance to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system.
Becton Dickinson and Co (19th May 2020): The Institutional Ownership as of today stood at 82.98%and the Total Value of Holdings (millions) is $ 62,281.
New Institutional Holders and other activity – As of today, the total number of shares held is 235,228,555 by 1,573 institutional holders.
20-May-2020:- Becton Dickinson and Co Expected to Earn Q3 2020 Earnings of $2.07 Per Share (NYSE: BDX)
Becton Dickinson and Co (NYSE: BDX) – Equities researchers at Piper Sandler cut their Q3 2020 earnings per share (EPS) estimates for shares of Becton Dickinson and in a report issued on Thursday, May 14th. Piper Sandler analyst W. Quirk now anticipates that the medical instruments supplier will post earnings of $2.07 per share for the quarter, down from their previous forecast of $3.21.
19-May-2020:- Woodley Farra Manion Portfolio Management Inc. Sells 205 Shares of Becton Dickinson and Co (NYSE: BDX)
Woodley Farra Manion Portfolio Management Inc. lowered its stake in shares of Becton Dickinson and Co (NYSE: BDX) by 42.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 273 shares of the medical instruments supplier’s stock after selling 205 shares during the quarter.
19-May-2020:- Broderick Brian C Boosts Holdings in Becton Dickinson and Co (NYSE: BDX)
Broderick Brian C grew its stake in shares of Becton Dickinson and Co (NYSE: BDX) by 29.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,114 shares of the medical instruments supplier’s stock after buying an additional 2,503 shares during the period.